Early Worsening of Retinopathy in Type 1 and Type 2 Diabetes After Rapid Improvement in Glycaemic Control: A Systematic Review Handan AkilJamie BurgessPhilip Burgess Review Open access 20 December 2021 Pages: 1 - 23
Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis Aditya RajuPratik PimpleSharash Shetty Original Research Open access 02 November 2021 Pages: 25 - 42
Improved Glycemic Control Observed in Children with Type 1 Diabetes Following the Introduction of Smart Insulin Pens: A Real-World Study Peter AdolfssonViktor BjörnssonElsa Ogionwo Lange Original Research Open access 08 November 2021 Pages: 43 - 56
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis Pierre GourdyRiccardo C. BonadonnaMireille Bonnemaire Original Research Open access 16 November 2021 Pages: 57 - 73
Patient Preferences for Pharmacological Diabetes Treatment Among People with Diabetes in Spain: A Discrete Choice Experiment Fernando Gómez-PeraltaMaría MarequeMiguel Ángel Casado Original Research Open access 18 November 2021 Pages: 75 - 87
Gut Microbiome Activity Contributes to Prediction of Individual Variation in Glycemic Response in Adults Hal TilyEric PatridgeGuruduth Banavar Original Research Open access 19 November 2021 Pages: 89 - 111
Insulin Pump Treatment in Adults with Type 1 Diabetes in the Capital Region of Denmark: Design and Cohort Characteristics of the Steno Tech Survey Karen RytterKristoffer P. MadsenSigne Schmidt Original Research Open access 22 November 2021 Pages: 113 - 129
Comparing Real-World Effectiveness of Dulaglutide and Insulin as the First Injectable for Patients with Type 2 Diabetes: An Australian Single-Site Retrospective Chart Review Jared A. HoussariniAlan J. M. BrnabicMarwan Obaid Original Research Open access 30 November 2021 Pages: 131 - 144
Prognostic Value of Stress Hyperglycemia in Patients Admitted to Medical/Geriatric Departments for Acute Medical Illness Raffaella Di LuzioRachele DusiGiampaolo Bianchi Original Research Open access 02 December 2021 Pages: 145 - 159
Efficacy of Dulaglutide in Chinese Patients with Type 2 Diabetes and Different Glycemic Patterns: a Post-hoc Analysis of the Phase 3 AWARD-CHN2 Trial Qifu LiQiqi ZhangTianpei Hong Original Research Open access 06 December 2021 Pages: 161 - 173
Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study) William H. PolonskyRiya AroraAndreas Liebl Original Research Open access 16 December 2021 Pages: 175 - 187
Are There Different Viewpoints About the Management of Type 2 Diabetes Mellitus and Comorbidities? A Multidisciplinary Spanish Qualitative Research Francesc-Xavier CosRicardo Gómez-HuelgasFernando Gomez-Peralta Original Research Open access 20 December 2021 Pages: 189 - 203
Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results Cristian GujaFrancesco GiorginoJulio Rosenstock Brief Report Open access 11 December 2021 Pages: 205 - 215
Letter to the Editor Regarding “Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study” Samaneh AsgariDavood KhaliliFarzad Hadaegh Letter Open access 03 December 2021 Pages: 217 - 219
A Response to the Letter to the Editor Regarding “Nationwide Prevalence of Diabetes and Prediabetes and Associated Risk Factors Among Iranian Adults: Analysis of Data from PERSIAN Cohort Study” to the end of Study Mohammad E. KhamsehSadaf G. SepanlouReza Malekzadeh Letter Open access 03 December 2021 Pages: 221 - 224